Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|
BT-20 | NVP-TAE684 | 0.1 | uM | 4 | 156.25 | 44.67 | 59.00 | 79.25 | 0.7445 | 0.4000 |
BT-20 | PLX-4720 | 10 | uM | 4 | 156.25 | 44.67 | 47.00 | 79.25 | 0.5931 | 0.0635 |
BT-20 | Nilotinib | 19.9526 | uM | 4 | 156.25 | 44.67 | 1018.00 | 79.25 | 12.8454 | 42.7898 |
BT-20 | 0 | uM | 4 | 156.25 | 44.67 | 82.00 | 79.25 | 1.0347 | 1.0842 | |
BT-20 | NVP-TAE684 | 3.1623 | uM | 4 | 156.25 | 44.67 | 42.00 | 79.25 | 0.5300 | -0.0717 |
BT-20 | Etoposide | 0.0033113 | uM | 4 | 156.25 | 44.67 | 69.00 | 79.25 | 0.8707 | 0.6917 |
BT-20 | PLX-4720 | 19.9526 | uM | 4 | 156.25 | 44.67 | 56.00 | 79.25 | 0.7066 | 0.3144 |
BT-20 | Etoposide | 3.1623 | uM | 4 | 156.25 | 44.67 | 65.00 | 79.25 | 0.8202 | 0.5739 |
BT-20 | NVP-TAE684 | 10 | uM | 4 | 156.25 | 44.67 | 44.00 | 79.25 | 0.5552 | -0.0180 |
BT-20 | 0 | uM | 4 | 156.25 | 44.67 | 74.00 | 79.25 | 0.9338 | 0.8410 | |
BT-20 | 0 | uM | 4 | 156.25 | 44.67 | 75.00 | 79.25 | 0.9464 | 0.8711 | |
BT-20 | 0 | uM | 4 | 312.50 | 138.79 | 233.00 | 296.50 | 0.7858 | 0.6049 | |
BT-20 | 0 | uM | 4 | 312.50 | 138.79 | 216.00 | 296.50 | 0.7285 | 0.4976 | |
BT-20 | Etoposide | 10 | uM | 4 | 312.50 | 138.79 | 121.00 | 296.50 | 0.4081 | -0.1177 |
BT-20 | 0 | uM | 4 | 312.50 | 138.79 | 304.00 | 296.50 | 1.0253 | 1.0461 | |
BT-20 | 0 | uM | 4 | 312.50 | 138.79 | 322.00 | 296.50 | 1.0860 | 1.1565 | |
BT-20 | Etoposide | 1 | uM | 4 | 312.50 | 138.79 | 266.00 | 296.50 | 0.8971 | 0.8113 |
BT-20 | NVP-TAE684 | 0.31623 | uM | 4 | 312.50 | 138.79 | 326.00 | 296.50 | 1.0995 | 1.1809 |
BT-20 | Nilotinib | 0.031623 | uM | 4 | 312.50 | 138.79 | 291.00 | 296.50 | 0.9815 | 0.9661 |
BT-20 | Nilotinib | 3.1623 | uM | 4 | 312.50 | 138.79 | 302.00 | 296.50 | 1.0185 | 1.0339 |
BT-20 | NVP-TAE684 | 0.01 | uM | 4 | 312.50 | 138.79 | 469.00 | 296.50 | 1.5818 | 2.0401 |
BT-20 | NVP-TAE684 | 0.0033113 | uM | 4 | 312.50 | 138.79 | 440.00 | 296.50 | 1.4840 | 1.8679 |
BT-20 | 0 | uM | 4 | 312.50 | 138.79 | 354.00 | 296.50 | 1.1939 | 1.3514 | |
BT-20 | Etoposide | 0.1 | uM | 4 | 312.50 | 138.79 | 443.00 | 296.50 | 1.4941 | 1.8858 |
BT-20 | PLX-4720 | 0.0033113 | uM | 4 | 312.50 | 138.79 | 347.00 | 296.50 | 1.1703 | 1.3089 |